Inhibitor Therapeutics (INTI) Cash flow

30 Followers

Inhibitor Therapeutics Cash Flow

INTI's free cash flow for Q4 2025 was $-601.16K. For the 2025 fiscal year, INTI's free cash flow was decreased by $1.68K and operating cash flow was $-601.16K. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -3.23M	$ -3.23M	$ -2.70M	$ 11.74M	$ -220.43K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 0.00	$ 0.00	$ -411.00K	$ 180.00K	$ 176.00K
End Cash Position	$ 2.38M	$ 5.61M	$ 8.84M	$ 11.95M	$ 30.63K
Free Cash Flow	$ -3.23M	$ -3.23M	$ -2.70M	$ 11.74M	$ -220.43K

Currency in USD